Your Messages Inbox
Your Article Summary
See Latest ArticlesImmunoGen, Inc. Prices Public Offering of Common Stock
ImmunoGen, Inc., 06/19/09
ImmunoGen, Inc. , a biopharmaceutical company that develops targeted anticancer therapeutics, announced that it has priced a public offering of 5,000,000 shares of its common stock at a price of $7.00 per share. Net proceeds, after underwriting discounts and commissions and expenses, will be approximately $33 million. ImmunoGen has granted the underwriters a thirty day option to purchase up to an additional 750,000 shares to cover over-allotments, if any.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09
Bayer CropScience signs Agreement with GVK Biosciences on early-stage research projects
BayNews International, 11/25/09
Reports Rate Ambulatory EHR Software
HealthDataManagement, 11/25/09
Article Search
Sponsor